INSIGHTS ON DRUG DEVELOPMENT
-
Inside Bioprocessing: Microbial Media
Learn the reasons why the animal origin-free trend in bioprocessing has taken so long to reach microbial bioproduction and the technical hurdles overcome during the development of Gibco CD Bacto Supreme.
-
Development Of A High Sensitivity SPE-LC-MS/MS Assay
Achieve ultra-sensitive glucagon quantification with ionKey/MS, μElution SPE, and advanced MS fragmentation to deliver low LOD, reduced sample loss, and enhanced confidence in results.
-
Futurizing Healthcare By Localizing The Life Sciences
Mustapha Bittaye's journey highlights the importance of international funding in fostering local scientific talent and biopharma resilience, empowering research and manufacturing in developing countries.
-
Cell Culture Media Demystified For Performance, Quality, And Innovation
Cell culture media isn’t one-size-fits-all. Learn how media composition, customization, and analytics can dramatically improve cell growth, productivity, and product quality for complex processes.
-
De-Risking Drug Development: Informatics-Supported Solid Form Selection5/6/2026
Learn how combining polymorph screening with structural informatics improves solid‑form selection, lowers development risk, and boosts confidence in long‑term stability and manufacturability.
-
Quality By Design: The Importance Of Reference Standards In Drug Development8/1/2024
Learn more about the comprehensive lifecycle management of reference standards, encompassing qualification, characterization, and storage procedures.
-
Advancing Cell Culture Strategies To Accelerate Biologics Development5/5/2026
Integrated stable expression strategies accelerate biologics material generation, improving scalability, consistency, and early developability insights while reducing bottlenecks, variability, and risks in transitioning from discovery to manufacturing.
-
Improve The Performance Of Your Small And Large Molecule Medicines7/23/2024
Explore the latest in nanotechnology advancements including recent clinical data, formulation applications, and API optimization to NanoImprove formulations.
-
KORSCH Virtual Pharma Expo September 2025: Oral Solid Dose Manufacturing And Packaging9/18/2025
Simulate high-speed tablet production early in development with minimal material. Gain accurate scale-up, faster material characterization, and flexible formulation options—all with one compaction simulator.
DRUG DEVELOPMENT SOLUTIONS
-
Nanoform’s GMP facility utilizes its award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology for the manufacture of API nanoparticles to GMP standards.
-
Minimize variability and improve detection confidence with high-purity analytical solvents. Discover how tightly controlled specifications support cleaner baselines and more reliable results.
-
Nanoform’s award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology is a bottom-up nanoparticle engineering approach that enables the creation of API nanoparticles and can unlock the full therapeutic potential of small molecule drugs.
-
Explore detailed product specifications and utilize a helpful decision tree to determine which organ-chip best meets the needs of your research.
-
Explore chromatography methods for sample preparation, residual solvent, and impurity analysis, critical steps for Active Pharmaceutical Ingredient (API) quality control.